IVFToday Prepare a consultation →

What screening can—and cannot—do

Donor screening: a transparent evidence and limitations checklist

Direct answer

Donor screening usually combines identity and consent checks with medical and family history, physical assessment, infectious-disease testing, selected genetic carrier screening and psychoeducational review. Requirements vary by country and donor type. Screening reduces selected risks; it does not guarantee future health, reveal every genetic condition or make a donor profile a complete medical record.

01 · Make the pathway visible

Six screening layers

  1. 01

    Identity and consent

    Verify who the donor is, the donation model and permissions for use, records and future information.

  2. 02

    Medical history

    Personal, reproductive and multi-generation family history with a process for material updates.

  3. 03

    Infectious disease

    Required questionnaire, examination, testing windows and any quarantine or re-testing rules.

  4. 04

    Genetic assessment

    Carrier screening, family-history interpretation, matching logic and counselling for residual risk.

  5. 05

    Psychosocial review

    Informed decision-making, pressure, expectations, disclosure and future-contact implications.

  6. 06

    Records and follow-up

    Retention, confidentiality, clinic access, health updates and donor-conceived information pathways.

02 · Compare like with like

What changes — and what to ask

What can vary

  • ✓ Country and regulator
  • ✓ Egg, sperm or embryo donation
  • ✓ Directed versus non-directed donation
  • ✓ Panel technology and record-retention rules

Questions to take forward

  • Which checks are legally required and which are clinic policy?
  • Who interprets genetic compatibility and residual risk?
  • How are future health updates handled?
  • What information is available to recipients and donor-conceived people?

Evidence boundary

What this page does not prove

  • No screening programme can identify every future medical or genetic outcome.
  • A longer test panel is not automatically better without appropriate interpretation and counselling.

03 · Common questions

Before you make a decision

01Does genetic carrier screening test every disease?

No. Panels cover selected conditions and leave residual risk even after a negative result.

02Are infectious-disease rules the same worldwide?

No. The required tests, timing, quarantine and use of directed donations vary by jurisdiction.

03Can a donor be screened once for life?

No. Guidance can require or recommend repeat evaluation, and new personal or family health information may become relevant.

04Should recipients see all donor medical data?

Access should follow consent, confidentiality, clinical relevance and applicable law, with sensitive records handled securely.

04 · Source trail

Primary references used

Reviewed by the IVFToday editorial team on 2026-08-31. Rules, data and clinical guidance can change.

Prepared questions. Better conversations.

Review a screening policy

Separate required tests, additional checks, interpretation and unresolved limitations.
Start privately →